[HTML] nih.gov

[HTML][HTML] LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

LC Brown, MD Tucker, R Sedhom… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …
被引用次数：78 相关文章

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

LC Brown, MD Tucker, R Sedhom… - … for ImmunoTherapy of …, 2021 - experts.umn.edu
Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

LC Brown, MD Tucker, R Sedhom… - Journal for …, 2021 - pure.johnshopkins.edu
Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …
[PDF] duke.edu

[PDF][PDF] LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

LC Brown, MD Tucker, R Sedhom, EB Schwartz, J Zhu… - dukespace.lib.duke.edu
Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

LC Brown, MD Tucker, R Sedhom… - Journal for …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types.

LC Brown, MD Tucker, R Sedhom… - … for Immunotherapy of …, 2021 - europepmc.org
Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …
[HTML] bmj.com

[HTML][HTML] LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

LC Brown, MD Tucker, R Sedhom… - … for ImmunoTherapy of …, 2021 - jitc.bmj.com
Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

LC Brown, MD Tucker… - Journal for …, 2021 - utsouthwestern.elsevierpure.com
Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

LC Brown, MD Tucker, R Sedhom… - Journal for …, 2021 - search.proquest.com
Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types.

LC Brown, MD Tucker, R Sedhom… - … for Immunotherapy of …, 2021 - europepmc.org
Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …